Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Elucidation of an anaerobic pathway for metabolism of l carnitinederived butyrobetaine to trimethylamine in human gut bacteria PNAS Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N Oxide The process of TMA TMAO's metabolism in human body. Food rich of Download Scientific Diagram Identification of Polymethoxyflavones (PMFs) from Orange Peel and Their Inhibitory Effects on the Formation of Trimethylamine (TMA) and Trimethylamine N oxide (TMAO) Using cntA B and cutC D Enzymes and Molecular Docking Journal of Agricultural